Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹55.53
1.43 (2.51%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹120 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹38.33+44.9%
52W High₹84.99-34.7%
Current Price
₹55.53
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹49.98
Upper Circuit₹61.08
Reference Price
₹55.53
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹48.8
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹48.8
Composite score -71.02 (STRONG_SELL) with 89.0% confidence
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Volume divergence: Bullish (price down, volume up)
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
89%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
60.25
EMA50
60.81
EMA200
64.46
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows3
Lower Highs7
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹57.40
₹60.21
₹61.96
₹62.85
₹63.88
Support (Below)
₹54.16
₹53.05
₹50.75
₹38.33
Volume Analysis
TrendINCREASING
Change+305.80%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹54.97
3% Risk₹53.86
5% Risk₹52.75
7% Risk (Custom)
₹51.64Technical Levels
1x ATR (Volatility)₹51.71
2x ATR (Swing)₹47.89
3x ATR (Trend)₹44.07
Immediate Support₹54.16
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹6.1 Cr | ₹5.5 Cr | ₹4.2 Cr | ₹7.3 Cr |
| Net Profit | ₹-8.3 Cr | ₹-5.3 Cr | ₹-6.1 Cr | ₹-3.1 Cr |
| EPS | — | ₹-2.47 | ₹-2.85 | ₹-1.45 |
| Operating Profit | ₹-5.1 Cr | ₹-2.1 Cr | ₹-2.8 Cr | ₹30,10,000 |
ROE
18.42%
ROCE
-31.85%
Debt/Equity
-1.45
Current Ratio
0.10
OPM
4.14%
NPM
-42.98%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Krebs Biochemicals and Industries Limited | ₹55.53 | -2.51% | — | ₹120 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2023 | Annual General Meeting | AGM |
| 15 Sept 2021 | Annual General Meeting | AGM |
| 16 Sept 2020 | Annual General Meeting | AGM |
| 13 Sept 2019 | Annual General Meeting | AGM |
| 31 Jan 2019 | Rights 21:100 @ Premium Rs 76 Per Share | RIGHTS_ISSUE |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KREBSBIO
View AllNEWS
negative
Business Standard - Markets 50d ago
Krebs Biochemicals & Industries reports standalone net loss of Rs 2.34 crore in the March 2026 quarter
Sales rise 11.64% to Rs 6.81 crore
KREBSBIOHealthcare